Published :
Tables : 50
Figures : 30
Category : Healthcare
No. of Pages : 250
Report Code : HC-1154
Sleep Apnea Devices Market Introduction Sleep Apnea Devices Market is estimated to value over USD 6 billion by 2027 end CAGR of over 10% during the forecast period from 2020 to 2027. The rising prevalence of sleep disorders in the global population is one of the main factors driving the growth of the global sleep apnea devices market. The rising geriatric population due to improved medical procedures also increases cases of sleep disorders and ailments among the population. According to the Sleep Apnea Organization, more than 22 million Americans experience sleep apnea disorder and 80% of moderate to severe sleep apnea cases were undiagnosed. On a global scale, over 100 million people collectively suffer from sleep apnea. Thus, the growing prevalence of sleep apnea as a major disorder affecting the majority of the population is one of the factors responsible for the growth of the sleep apnea devices market. Obstructive sleep apnea (OSA) is a prevalent ailment, which affects about 20% of the world population, thus demanding medical solutions and remedies in high numbers. It is a chronic and fatal sleep sickness that is widely undiagnosed and overlooked. However, various government initiatives are benefiting patients by raising awareness about OSA. For instance, in the United States, the American Sleep Apnea Association (ASAA) was founded in 1990, advances awareness regarding sleep apnea, advocates for sustainable developments in therapies for this severe complication, and works in the interest of the patients. The factors, such as heightened occurrences of sleep apnea, growing consciousness among the patient population in the developing countries, favorable government initiatives, and forthcoming technological advancements, are expected to drive the growth of the market over the forecast period. An increasingly sedentary lifestyle with serious alterations leading to grave side-effects, resulting in cardiovascular disease, erratic sleep patterns, and high frequencies of stress and obesity, will continue to boost the industry's development. All of these factors increase the prevalence of sleep apnea. The inadequacy of patient conformity and significant healthcare costs are predicted to restrict the development of the market. Advances in technology to improve sleep apnea devices have led to the growth of a range of standard sleep apnea therapies. Moreover, continuous efforts both in private and public sectors to develop efficient equipment and cures, raise global demand. The untapped potential in emerging countries will expand the market over the forecast period. Raised consciousness and a positive reimbursement scenario will improve the adoption rate. North America led the global market with the largest market share. An extensive patient pool and the presence of established manufacturers helps the growth of the market and is further anticipated to augment the regional demand. Rising concerns regarding health risks arising out of sleep apnea is promoting the market growth. Technological improvements in diagnostic and therapeutic devices and accessibility of products like the Elastic Mandibular Advancements (EMA), is another factor promoting the regional revenue growth. The Asia Pacific is projected to be the fastest-growing market over the forecast period. A large patient pool with an increasing number of clinics is anticipated to promote robust growth. Manufacturers are concentrating on fabricating policies towards enhancing their customer base through the introduction of affordable devices for price-sensitive customers in the Asia Pacific. Sleep Apnea Devices Market is majorly occupied by firms such as: ResMed, Koninklijke Philips, Fisher & Paykel Healthcare, SomnoMed, Oventus Medical, Compumedics, Löwenstein Medical, Drive DeVilbiss Healthcare, BMC Medical, Braebon Medical and Panthera Dental Sleep Apnea Devices Market Segmentation: By Type Therapeutic Devices Diagnostic Devices By End User Sleep Laboratories & Hospitals Home Care Settings/Individuals By Region Europe North America APAC Latin America Rest of World Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways: Growth prospects SWOT analysis Key trends Key data points affecting market growth Objectives of the Study: To provide an exhaustive analysis on the global sleep apnea market by type, by end-user, and by region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the rest of the world To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Sleep Apnea Devices Market is estimated to value over USD 6 billion by 2027 end CAGR of over 10% during the forecast period from 2020 to 2027.
The rising prevalence of sleep disorders in the global population is one of the main factors driving the growth of the global sleep apnea devices market. The rising geriatric population due to improved medical procedures also increases cases of sleep disorders and ailments among the population. According to the Sleep Apnea Organization, more than 22 million Americans experience sleep apnea disorder and 80% of moderate to severe sleep apnea cases were undiagnosed. On a global scale, over 100 million people collectively suffer from sleep apnea. Thus, the growing prevalence of sleep apnea as a major disorder affecting the majority of the population is one of the factors responsible for the growth of the sleep apnea devices market.
Obstructive sleep apnea (OSA) is a prevalent ailment, which affects about 20% of the world population, thus demanding medical solutions and remedies in high numbers. It is a chronic and fatal sleep sickness that is widely undiagnosed and overlooked. However, various government initiatives are benefiting patients by raising awareness about OSA. For instance, in the United States, the American Sleep Apnea Association (ASAA) was founded in 1990, advances awareness regarding sleep apnea, advocates for sustainable developments in therapies for this severe complication, and works in the interest of the patients. The factors, such as heightened occurrences of sleep apnea, growing consciousness among the patient population in the developing countries, favorable government initiatives, and forthcoming technological advancements, are expected to drive the growth of the market over the forecast period.
An increasingly sedentary lifestyle with serious alterations leading to grave side-effects, resulting in cardiovascular disease, erratic sleep patterns, and high frequencies of stress and obesity, will continue to boost the industry's development. All of these factors increase the prevalence of sleep apnea. The inadequacy of patient conformity and significant healthcare costs are predicted to restrict the development of the market.
Advances in technology to improve sleep apnea devices have led to the growth of a range of standard sleep apnea therapies. Moreover, continuous efforts both in private and public sectors to develop efficient equipment and cures, raise global demand. The untapped potential in emerging countries will expand the market over the forecast period. Raised consciousness and a positive reimbursement scenario will improve the adoption rate.
North America led the global market with the largest market share. An extensive patient pool and the presence of established manufacturers helps the growth of the market and is further anticipated to augment the regional demand. Rising concerns regarding health risks arising out of sleep apnea is promoting the market growth. Technological improvements in diagnostic and therapeutic devices and accessibility of products like the Elastic Mandibular Advancements (EMA), is another factor promoting the regional revenue growth.
The Asia Pacific is projected to be the fastest-growing market over the forecast period. A large patient pool with an increasing number of clinics is anticipated to promote robust growth. Manufacturers are concentrating on fabricating policies towards enhancing their customer base through the introduction of affordable devices for price-sensitive customers in the Asia Pacific.
Sleep Apnea Devices Market is majorly occupied by firms such as:
ResMed, Koninklijke Philips, Fisher & Paykel Healthcare, SomnoMed, Oventus Medical, Compumedics, Löwenstein Medical, Drive DeVilbiss Healthcare, BMC Medical, Braebon Medical and Panthera Dental
Sleep Apnea Devices Market Segmentation:
By Type
By End User
By Region
Competitive Landscape:
FutureWise Takeaways:
Objectives of the Study:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Sleep Apnea Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Sleep Apnea Devices Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Sleep Apnea Devices Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Sleep Apnea Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Sleep Apnea Devices Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Therapeutic Devices 7.2. Diagnostic Devices 8. Global Sleep Apnea Devices Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Sleep Laboratories & Hospitals 8.2. Home Care Settings/Individuals 9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 14.1. ResMed 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Koninklijke Philips 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Fisher & Paykel Healthcare 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. SomnoMed 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Oventus Medical 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. Compumedics 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Löwenstein Medical 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. Drive DeVilbiss Healthcare 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. BMC Medical 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10. Braebon Medical 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11. Panthera Dental 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics